Q2 2026 Holdings
Filed 2026-08-11 | 76 holdings | $664.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Space Exploration Techn Corp(SPCX) | CLASS A COM STK | 84615Q103 | $239.0M | 1,398,815 | 36.0% |
| Aktis Oncology Inc(AKTS) | COM | 01021M104 | $99.0M | 3,070,219 | 14.9% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $28.0M | 1,539,764 | 4.2% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $27.9M | 9,163,157 | 4.2% |
| Nuveen Churchill Direct Lend(NCDL) | COM SHS | 67090S108 | $26.6M | 2,143,626 | 4.0% |
| Maplight Therapeutics Inc(MPLT) | COM | 56565P103 | $26.2M | 729,929 | 3.9% |
| Capital One Finl Corp(COF) | COM | 14040H105 | $24.0M | 119,757 | 3.6% |
| Blue OWL Capital Corporation(OBDC) | COM | 69121K104 | $22.2M | 2,045,070 | 3.3% |
| Deep Fission Inc(FISN) | COM | 243927100 | $14.7M | 1,333,333 | 2.2% |
| Dell Technologies Inc(DELL) | CL C | 24703L202 | $14.2M | 32,961 | 2.1% |
| Holley Inc(HLLY) | COM | 43538H103 | $11.2M | 4,376,888 | 1.7% |
| Eyepoint Inc(EYPT) | COM NEW | 30233G209 | $10.9M | 762,594 | 1.6% |
| Sagimet Biosciences Inc(SGMT) | COM SER A | 786700104 | $9.7M | 1,260,544 | 1.5% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $9.1M | 608,600 | 1.4% |
| Artiva Biotherapeutics Inc(ARTV) | COM | 04317A107 | $8.5M | 874,542 | 1.3% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $7.9M | 3,624,076 | 1.2% |
| Conduent Inc(CNDT) | COM | 206787103 | $7.4M | 5,036,595 | 1.1% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $6.8M | 61,455 | 1.0% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $6.4M | 450,000 | 1.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $6.1M | 182,638 | 0.9% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $5.5M | 36,259 | 0.8% |
| Imagenebio Inc(IMA) | COM | 45175G207 | $5.4M | 917,692 | 0.8% |
| Compass Pathways PLCCall | CALL | 20451W901 | $5.2M | 1,670,500 | 0.8% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $4.8M | 260,000 | 0.7% |
| Immix Biopharma Inc(IMMX) | COM | 45258H106 | $4.5M | 437,552 | 0.7% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $4.3M | 400,000 | 0.7% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $4.3M | 756,722 | 0.6% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $3.9M | 942,932 | 0.6% |
| Starwood Ppty TR Inc(STWD) | COM | 85571B105 | $3.2M | 196,355 | 0.5% |
| Evommune Inc(EVMN) | COM SHS | 30054Y107 | $2.4M | 180,000 | 0.4% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $2.2M | 566,509 | 0.3% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $2.2M | 714,710 | 0.3% |
| Chime Finl Inc(CHYM) | COM SHS CL A | 16935C109 | $1.8M | 89,878 | 0.3% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $1.6M | 2,934,015 | 0.2% |
| WW Intl Inc(WW) | COM | 98262P200 | $1.3M | 84,399 | 0.2% |
| Marker Therapeutics Inc(MRKR) | COM NEW | 57055L206 | $814.7K | 554,250 | 0.1% |
| Erasca IncCall | CALL | 29479A908 | $795.0K | 100,000 | 0.1% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $784.9K | 733,568 | 0.1% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $396.0K | 59,911 | 0.1% |
| Fold Hldgs Inc(FLD) | COM CL A | 29103K100 | $385.5K | 856,632 | 0.1% |
| Niocorp Devs LTD(NIOBW) | *W EXP 03/17/202 | 654484153 | $381.0K | 268,280 | 0.1% |
| Eledon Pharmaceuticals IncCall | CALL | 28617K901 | $285.0K | 200,000 | 0.0% |
| Rezolve AI PLC | *W EXP 08/15/202 | G75398118 | $214.0K | 235,121 | 0.0% |
| Brand Engagement Network Inc(BNAIW) | *W EXP 03/14/202 | 104932116 | $203.5K | 1,453,808 | 0.0% |
| Piper Sandler Companies(PIPR) | COM NEW | 724078209 | $175.6K | 2,428 | 0.0% |
| Engene Therapeutics Inc | *W EXP 10/31/202 | 29286X119 | $148.2K | 511,177 | 0.0% |
| Larimar Therapeutics IncCall | CALL | 517125900 | $145.7K | 728,600 | 0.0% |
| Celcuity Inc(CELC) | COM | 15102K100 | $130.7K | 1,249 | 0.0% |
| Compass Therapeutics IncCall | CALL | 20454B904 | $106.3K | 303,800 | 0.0% |
| Stablecoinx Inc | *W EXP 06/25/203 | 85238K118 | $102.5K | 250,000 | 0.0% |